These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9176043)

  • 1. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid.
    Eldrup E; Møller SE; Andreasen J; Christensen NJ
    Clin Sci (Lond); 1997 Apr; 92(4):423-30. PubMed ID: 9176043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
    Eldrup E; Clausen N; Scherling B; Schmiegelow K
    Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
    Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
    Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOPA, dopamine, and DOPAC concentrations in the rat gastrointestinal tract decrease during fasting.
    Eldrup E; Richter EA
    Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E815-22. PubMed ID: 11001763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
    Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
    J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans.
    Eldrup E; Hetland ML; Christensen NJ
    Eur J Clin Invest; 1994 Mar; 24(3):205-11. PubMed ID: 8033956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Hetland ML; Eldrup E; Bratholm P; Christensen NJ
    Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
    Shigetomi S; Kuchel O
    Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
    Vieira-Coelho MA; Pestana M; Soares-da-Silva P
    Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
    Cummings J; Matheson LM; Smyth JF
    J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure.
    Yamamoto T; Polinsky RJ; Goldstein DS; Baucom CE; Kopin IJ
    J Lab Clin Med; 1996 Nov; 128(5):488-91. PubMed ID: 8900291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.
    Holmes C; Eisenhofer G; Goldstein DS
    J Chromatogr B Biomed Appl; 1994 Mar; 653(2):131-8. PubMed ID: 8205240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection.
    Goldstein DS; Stull R; Zimlichman R; Levinson PD; Smith H; Keiser HR
    Clin Chem; 1984 May; 30(5):815-6. PubMed ID: 6424968
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid procedure for chromatographic isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels.
    Dalmaz Y; Peyrin L
    J Chromatogr; 1978 Jan; 145(1):11-27. PubMed ID: 621235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-performance liquid chromatography with a novel type of electrochemical detection.
    Westerink BH; Mulder TB
    J Neurochem; 1981 Apr; 36(4):1449-62. PubMed ID: 6167673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance and origin of DOPA, DOPAC, and dopamine-sulphate in plasma, tissues and cerebrospinal fluid.
    Eldrup E
    Dan Med Bull; 2004 Feb; 51(1):34-62. PubMed ID: 16009071
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations.
    Rasmussen DD; Ishizuka B; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1983 Oct; 57(4):760-3. PubMed ID: 6885965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.
    Fornstedt Wallin B
    J Neural Transm (Vienna); 2024 Mar; 131(3):213-228. PubMed ID: 38238531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.